2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Topical anti-glaucomatous medications are still the most important measure to lower intraocular pressure. Large number of studies have confirmed that long-term use of anti-glaucomatous eye drops, especially containing benzalkonium chloride, a preservative, can cause or aggravate ocular surface injury. Ocular surface diseases damage the ocular microenvironmental health status, reduce the patients’ compliance with the treatment, and finally affect the treatment result. Therefore, the ocular surface management of patients with glaucoma is very important. This includes the selection of drugs that are better tolerated according to individual conditions, preservative-free formulations, drugs that protect against ocular surface disease, or selecting surgery and laser treatment, to prevent the damage to the ocular surface by topical anti-glaucomatous drugs.

          Related collections

          Most cited references161

          • Record: found
          • Abstract: found
          • Article: not found

          TFOS DEWS II Epidemiology Report

          The subcommittee reviewed the prevalence, incidence, risk factors, natural history, morbidity and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta-analysis of published prevalence data estimated the impact of age and sex. Global mapping of prevalence was undertaken. The prevalence of DED ranged from 5 to 50%. The prevalence of signs was higher and more variable than symptoms. There were limited prevalence studies in youth and in populations south of the equator. The meta-analysis confirmed that prevalence increases with age, however signs showed a greater increase per decade than symptoms. Women have a higher prevalence of DED than men, although differences become significant only with age. Risk factors were categorized as modifiable/non-modifiable, and as consistent, probable or inconclusive. Asian ethnicity was a mostly consistent risk factor. The economic burden and impact of DED on vision, quality of life, work productivity, psychological and physical impact of pain, are considerable, particularly costs due to reduced work productivity. Questionnaires used to evaluate DED vary in their utility. Future research should establish the prevalence of disease of varying severity, the incidence in different populations and potential risk factors such as youth and digital device usage. Geospatial mapping might elucidate the impact of climate, environment and socioeconomic factors. Given the limited study of the natural history of treated and untreated DED, this remains an important area for future research.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.

            The Ocular Hypertension Treatment Study (OHTS) has shown that topical ocular hypotensive medication is effective in delaying or preventing the onset of primary open-angle glaucoma (POAG) in individuals with elevated intraocular pressure (ocular hypertension) and no evidence of glaucomatous damage. To describe baseline demographic and clinical factors that predict which participants in the OHTS developed POAG. Baseline demographic and clinical data were collected prior to randomization except for corneal thickness measurements, which were performed during follow-up. Proportional hazards models were used to identify factors that predicted which participants in the OHTS developed POAG. In univariate analyses, baseline factors that predicted the development of POAG included older age, race (African American), sex (male), larger vertical cup-disc ratio, larger horizontal cup-disc ratio, higher intraocular pressure, greater Humphrey visual field pattern standard deviation, heart disease, and thinner central corneal measurement. In multivariate analyses, baseline factors that predicted the development of POAG included older age, larger vertical or horizontal cup-disc ratio, higher intraocular pressure, greater pattern standard deviation, and thinner central corneal measurement. Baseline age, vertical and horizontal cup-disc ratio, pattern standard deviation, and intraocular pressure were good predictors for the onset of POAG in the OHTS. Central corneal thickness was found to be a powerful predictor for the development of POAG.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              TFOS DEWS II iatrogenic report

                Bookmark

                Author and article information

                Contributors
                duanxchu@csu.edu.cn
                Journal
                Ophthalmol Ther
                Ophthalmol Ther
                Ophthalmology and Therapy
                Springer Healthcare (Cheshire )
                2193-8245
                2193-6528
                9 August 2022
                9 August 2022
                October 2022
                : 11
                : 5
                : 1681-1704
                Affiliations
                [1 ]Changsha Aier Eye Hospital, Changsha, Hunan Province China
                [2 ]GRID grid.452708.c, ISNI 0000 0004 1803 0208, The Second Xiangya Hospital, Central South University, ; Changsha, Hunan Province China
                [3 ]GRID grid.216417.7, ISNI 0000 0001 0379 7164, Aier School of Ophthalmology, , Central South University, ; Changsha, Hunan Province China
                Author information
                http://orcid.org/0000-0002-3148-1703
                Article
                557
                10.1007/s40123-022-00557-0
                9437175
                35943668
                0d5bbf54-51b7-477d-ba62-653c8def4ccf
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 1 July 2022
                : 29 July 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81970801
                Award Recipient :
                Funded by: the Hunan Province research and development plan funding projects in key areas
                Award ID: 2020SK2133
                Award Recipient :
                Funded by: the Science and Technology Foundation of Changsha, Hunan, China
                Award ID: kh1801229
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004735, Natural Science Foundation of Hunan Province;
                Award ID: 2019JJ40001
                Award Recipient :
                Funded by: the Science and Technology Foundation of Aier Eye Hospital Group, China
                Award ID: AR1906D1
                Award ID: AM1906D2
                Award Recipient :
                Categories
                Review
                Custom metadata
                © The Author(s) 2022

                anti-glaucomatous medications,benzalkonium chloride,ocular surface disease,preservative-free formulation

                Comments

                Comment on this article